InVivo raising $14M for spinal trial; Argon rolls out dialysis tech;

@FierceMedDev: Mindray Medical revenue jumps up by 9% in Q1. More | Follow @FierceMedDev

@VarunSaxena2: Apple on medical tech hiring spree, a possible hint of iWatch plans. Story | Follow @VarunSaxena2

@EmilyWFierce: California high court to decide whether retailers should have defibrillators on hand for stricken customers. Article | Follow @EmilyWFierce

@MichaelGFierce: Icon's Verisome-delivered cataract inflammation treatment enters PhIII. Release | Follow @MichaelGFierce

> InVivo ($NVIV) is raising $14 million to help complete the long-delayed study of its Neuro-Spinal Scaffold. News

> Argon Medical Devices has launched its CleanerXT Rotational Thrombectomy System, part of its franchise of dialysis devices. Item

> Qiagen ($QGEN) picked up FDA clearance for its latest C. difficile diagnostic. More

Biotech News

@FierceBiotech: AstraZeneca promises investors a magnificent future--without Pfizer. Story | Follow @FierceBiotech

@JohnCFierce: Some of the new OKs at Merck won't amount to much, some will. Collectively, though, it's a breakthrough. Great to see. | Follow @JohnCFierce

@DamianFierce: Breakthrough melanoma prospect MK-3475 has an FDA decision date set for Oct. 28. Release | Follow @DamianFierce

@EmilyMFierce: Hormone could be key to reversing the aging process. More | Follow @EmilyMFierce

> Loxo lands $24M venture round and a CSO for cancer drug research. Story

> Merck pays $1B to buy into Bayer's cardio future. Article

> AstraZeneca promises investors a magnificent future--without Pfizer. Report

Pharma News

@FiercePharma: Cancer-drug market zooms toward $100B, thanks to costly targeted therapies. Article | Follow @FiercePharma

@TracyStaton: Convicted U.S. soldier blames Pfizer's controversial stop-smoking drug Chantix for inexplicable murder. Story via McClatchy | Follow @TracyStaton

@EricPFierce: CEO says Teva will close at least 11 plants, 15% of its network, and 16 more are being evaluated. Story | Follow @EricPFierce

@CarlyHFierce: ICYMI yesterday: Sanofi's Shan5 overcomes manufacturing setback to score thumbs up from WHO. More from FierceVaccines | Follow @CarlyHFierce

> Loud opposition to Pfizer's AstraZeneca takeover prompts Parliamentary probe. Story

> Bayer aims to crush consumer health rivals with $14B Merck unit buyout. More

Biotech Research News

> UCSF, Stanford and Johns Hopkins join FDA partnership to speed drug development. More

> Fast-acting antidepressant shows continued relief in animals. Story

> Technique aims to more accurately test pharmaceuticals. Item

> Harvard's bone marrow-on-a-chip could replace animal drug testing. Article

> Novavax, U. of Maryland report positive preclinical results for MERS vaccine. More

Pharma Manufacturing News

> Sanofi's Shantha Biotechnics gets manufacturing issues resolved. News

> Caraco plant in Detroit being shut down by Sun Pharma. Article

> FDA smacks Mexican facility that makes scorpion antivenom for U.S. Story

> Italian mafia at center of network that stole vials of Roche's Herceptin. Report

> Teva whacking 11 plants for sure, another 16 being evaluated. More

Suggested Articles

Flatiron has hired a new chief medical officer as it looks to push on under its new parent in the world of electronic health records and real-world data.

Saga Diagnostics has raised 40 million Swedish kronor, or about $4.1 million, to help develop its ultrasensitive cancer liquid biopsy tests.

Terumo will help Orchestra BioMed develop its sirolimus-eluting balloon in both coronary and peripheral cardiovascular interventions.